Staff member and alumnus, Professor Brian Trudinger has made two gifts to the University of Sydney from his foundation: a 100 per cent share in Westmead IVF Pty Limited and $10.4 million.
Brian Trudinger, Professor of Obstetrics, Gynaecology at the University of Sydney, has been custodian of the Westmead Fertility Centre – the private fertility clinic at Westmead Hospital – for the past 22 years. He is also the 100 per cent shareholder of Westmead IVF Pty Limited, the company which operates the Centre.
This week Trudinger has not only gifted his stake in Westmead IVF to the University, but he has also made a $10.4 million cash donation to establish both a chair in reproductive endocrinology and infertility, and endow a research program in maternal foetal medicine.
“This would collocate the two phases of reproduction, falling pregnant and carrying a pregnancy to a successful outcome,” says a University statement.
Professor Trudinger (below on right) says he sees the University of Sydney as the natural guardian of a fertility service with core values of quality, accessibility and scientific enquiry:
“The strength of the University in research and academic activity would be a great benefit to the hospital. I am delighted the University has so enthusiastically embraced this venture.”
The Dean of Sydney Medical School, Professor Bruce Robinson, expressed his sincere gratitude for the donation, saying, “This gift brings together the link between clinical service, research and teaching for which Sydney Medical School and the University are renowned”.
The gift has been welcomed by both the Western Sydney Local Health District (WSLHD) and Westmead Hospital. Emeritus Professor Stephen Leeder, Board Chair of WSLHD, said improved health outcomes resulted from partnerships in a continuum of translational research from the laboratory to the bedside.
“This endowment and gift will enable the University of Sydney and the Western Sydney Local Health District at Westmead Hospital to strengthen their contribution to providing the best possible care at the beginning of life. Professor Trudinger and his colleagues have done superbly in this field and I am confident they will continue to do so through future research and clinical services,” he said.